Literature DB >> 16236490

Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis.

Pelagia G Tsoutsou1, Konstantinos I Gourgoulianis, Efthymia Petinaki, Anastassios Germenis, Anthousa G Tsoutsou, Maria Mpaka, Smaragda Efremidou, Pashalis-Adam Molyvdas.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative disorder. Cytokines contribute an important but yet undefined role to its pathogenesis.
OBJECTIVES: The present study aims to compare serum levels of cytokines involved in Th-1 and Th-2 immunity, such as interleukins (IL) IL-2, IL-4, IL-8, IL-10, interferon-gamma (IFN-gamma) and IL-12 (p40) in patients with IPF and healthy volunteers. Twenty patients with IPF and 40 healthy controls (HC) participated.
METHODS: Cytokines were assessed by enzyme-linked immunoabsorbent assay (ELISA).
RESULTS: Median values of serum IL-2, IL-8, IL-10, IL-12 (p40) were higher in the IPF than the control group: IPF group: 1.05 U/ml, 12.55, 10.13, 44.17 pg/ml; control group: 0.05 U/ml, 6.91, 0.75, 4.51 pg/ml, respectively (P<0.05). IFN-gamma serum levels were lower in the IPF (0.19 pg/ml) than in the control group (0.49 pg/ml). IL-4 values did not differ in a statistically significant way among the groups: 8.40 pg/ml in the IPF group, and 7.46 pg/ml in the control group (P>0.05). IL-4 positively correlated to fast expiratory volume in 1s (FEV1%) and forced vital capacity (FVC%), while IL-8 negatively correlated to the respective values (P<0.005).
CONCLUSIONS: IL-2, IL-8, IL-10 and IL-12 (p40) were found to be elevated in the sera of patients with IPF. IFN-gamma was found to be decreased in the sera of patients with IPF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236490     DOI: 10.1016/j.rmed.2005.06.016

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  21 in total

1.  Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.

Authors:  Vishwaraj Sontake; Shiva K Shanmukhappa; Betsy A DiPasquale; Geereddy B Reddy; Mario Medvedovic; William D Hardie; Eric S White; Satish K Madala
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

2.  Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damage.

Authors:  Michael G Haase; Anke Klawitter; Peter Geyer; Gustavo B Baretton
Journal:  J Histochem Cytochem       Date:  2007-08-06       Impact factor: 2.479

3.  Role of hypoxia-inducible factor 1, α subunit and cAMP-response element binding protein 1 in synergistic release of interleukin 8 by prostaglandin E2 and nickel in lung fibroblasts.

Authors:  Kelly A Brant; James P Fabisiak
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

4.  Nickel alterations of TLR2-dependent chemokine profiles in lung fibroblasts are mediated by COX-2.

Authors:  Kelly A Brant; James P Fabisiak
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

5.  Macrophage-derived biomarkers of idiopathic pulmonary fibrosis.

Authors:  E Bargagli; A Prasse; C Olivieri; J Muller-Quernheim; P Rottoli
Journal:  Pulm Med       Date:  2010-11-29

Review 6.  Molecular biomarkers in interstitial lung diseases.

Authors:  Angelo De Lauretis; Elisabetta A Renzoni
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

7.  Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.

Authors:  Takafumi Niwamoto; Tomohiro Handa; Yuko Murase; Yoshinari Nakatsuka; Kiminobu Tanizawa; Yoshio Taguchi; Hiromi Tomioka; Keisuke Tomii; Hideo Kita; Michihiro Uyama; Michiko Tsuchiya; Masahito Emura; Tetsuji Kawamura; Naoki Arai; Machiko Arita; Kazuko Uno; Akihiko Yoshizawa; Ryuji Uozumi; Izumi Yamaguchi; Fumihiko Matsuda; Kazuo Chin; Toyohiro Hirai
Journal:  Respir Res       Date:  2021-06-17

Review 8.  Macrophage heterogeneity in respiratory diseases.

Authors:  Carian E Boorsma; Christina Draijer; Barbro N Melgert
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

Review 9.  Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response.

Authors:  Willis S Bowman; Gabrielle A Echt; Justin M Oldham
Journal:  Front Med (Lausanne)       Date:  2021-05-10

Review 10.  The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis.

Authors:  Siavash Bolourani; Max Brenner; Ping Wang
Journal:  J Mol Med (Berl)       Date:  2021-07-13       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.